Cytokine Hub Classification of PASC, ME-CFS and other PASC-like Conditions

Abstract

Background Post-acute sequelae of COVID-19 (PASC) is a growing healthcare and economic concern affecting as many as 10%-30% of those infected with COVID-19. Though the symptoms have been well-documented, they significantly overlap with other common chronic inflammatory conditions which could confound treatment and therapeutic trials. Methods A total of 236 patients including 64 with post-acute sequelae of COVID-19 (PASC), 50 with myalgic encephalomyelitis-chronic fatigue syndrome (ME-CFS), 29 with post-treatment Lyme disease (PTLD), and 42 post-vaccine individuals with PASC-like symptoms (POVIP) were enrolled in the study. We performed a 14-plex cytokine/chemokine panel previously described to generate raw data that was normalized and run in a decision tree model using a Classification and Regression Tree (CART) algorithm. The algorithm was used to classify these conditions in distinct groups despite their similar symptoms. Results PASC, ME-CSF, POVIP, and Acute COVID-19 disease categories were able to be classified by our cytokine hub based CART algorithm with an average F1 score of 0.61 and high specificity (94%). Conclusions Proper classification of these inflammatory conditions with very similar symptoms is critical for proper diagnosis and treatment.

Scrutinizing Clinical Biomarkers in a Large Cohort of Patients with Lyme Disease and Other Tick-Borne Infections

“…Cytokine profiling and clinical biomarkers can differentiate other infections and autoimmune diseases from TBIs. One study demonstrated that cytokine profiles of post-acute sequelae of COVID-19, post-treatment Lyme disease, and myalgic encephalomyelitis-chronic fatigue syndrome were distinct [ 68 ]. Future analysis into cytokines could determine how immune interactions affect the disease course of TBIs.…”